FDA approves many drugs that predictably increase heart and stroke risk


The US Food and Drug Administration (FDA), an agency charged to protect patients from dangerous drug side effects needs to be far more vigilant when it comes to medications that affect blood pressure, according to an article published by clinical professor of family medicine Robert P. Blankfield, MD, MS, in an online edition of the Journal of Cardiovascular Pharmacology and Therapeutics. The editorial notes that several medications survived FDA scrutiny, only to be pulled from the market after reports of increased heart attacks and strokes related to use of the drugs. These include rofecoxib (Vioxx), valdecoxib (Bextra), and sibutramine (Meridia), all of which raise blood pressure.

Read the source article at Breaking World Pharma News

About the Author

Leave a Reply